<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Improving Batch Manufacturing Quality Review Cycle Time</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/improving-batch-manufacturing-quality-review-cycle-time-1834757106</link><description>Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>